BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hartl N, Adams F, Merkel OM. From adsorption to covalent bonding: Apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood-brain barrier. Adv Ther (Weinh) 2021;4:2000092. [PMID: 33542947 DOI: 10.1002/adtp.202000092] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang D, Tian S, Liu Y, Zheng M, Yang X, Zou Y, Shi B, Luo L. Near infrared-activatable biomimetic nanogels enabling deep tumor drug penetration inhibit orthotopic glioblastoma. Nat Commun 2022;13:6835. [PMID: 36369424 DOI: 10.1038/s41467-022-34462-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Paramanick D, Singh VD, Singh VK. Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases. Journal of Controlled Release 2022;351:638-655. [DOI: 10.1016/j.jconrel.2022.09.058] [Reference Citation Analysis]
3 Gabold B, Adams F, Brameyer S, Jung K, Ried CL, Merdan T, Merkel OM. Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins. Drug Deliv Transl Res 2022. [PMID: 36207657 DOI: 10.1007/s13346-022-01245-z] [Reference Citation Analysis]
4 Kong J, Chu R, Wang Y. Neuroprotective Treatments for Ischemic Stroke: Opportunities for Nanotechnology. Adv Funct Materials. [DOI: 10.1002/adfm.202209405] [Reference Citation Analysis]
5 Montegiove N, Calzoni E, Emiliani C, Cesaretti A. Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases. JFB 2022;13:125. [DOI: 10.3390/jfb13030125] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Pandey N, Anastasiadis P, Carney CP, Kanvinde PP, Woodworth GF, Winkles JA, Kim AJ. Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment. Adv Drug Deliv Rev 2022;:114415. [PMID: 35787387 DOI: 10.1016/j.addr.2022.114415] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ferhan AR, Park S, Park H, Tae H, Jackman JA, Cho N. Lipid Nanoparticle Technologies for Nucleic Acid Delivery: A Nanoarchitectonics Perspective. Adv Funct Materials. [DOI: 10.1002/adfm.202203669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wei J, Wu D, Shao Y, Guo B, Jiang J, Chen J, Zhang J, Meng F, Zhong Z. ApoE-mediated systemic nanodelivery of granzyme B and CpG for enhanced glioma immunotherapy. J Control Release 2022:S0168-3659(22)00244-9. [PMID: 35513207 DOI: 10.1016/j.jconrel.2022.04.048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Liu Y, Wang W, Zhang D, Sun Y, Li F, Zheng M, Lovejoy DB, Zou Y, Shi B. Brain co‐delivery of first‐line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy. Exploration. [DOI: 10.1002/exp.20210274] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
10 Al Gailani M, Liu M, Wen J. Ligands for oral delivery of peptides across the blood-brain-barrier. Acta Materia Medica 2022;1. [DOI: 10.15212/amm-2021-0007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Singh P, Madhav H, Singh N, Jaiswar G, Nishat N. Influence of different amino functional groups on structural, optical, and morphological properties of PMMA and their nanocomposites. Polymer Engineering & Sci 2022;62:824-831. [DOI: 10.1002/pen.25888] [Reference Citation Analysis]
12 Nasseri B, Alizadeh E, Bani F, Davaran S, Akbarzadeh A, Rabiee N, Bahadori A, Ziaei M, Bagherzadeh M, Saeb MR, Mozafari M, Hamblin MR. Nanomaterials for photothermal and photodynamic cancer therapy. Applied Physics Reviews 2022;9:011317. [DOI: 10.1063/5.0047672] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
13 Khan H, Nazir S, Farooq RK, Khan IN, Javed A. Fabrication and Assessment of Diosgenin Encapsulated Stearic Acid Solid Lipid Nanoparticles for Its Anticancer and Antidepressant Effects Using in vitro and in vivo Models. Front Neurosci 2022;15:806713. [DOI: 10.3389/fnins.2021.806713] [Reference Citation Analysis]
14 Joy R, George J, John F. Brief Outlook on Polymeric Nanoparticles, Micelles, Niosomes, Hydrogels and Liposomes: Preparative Methods and Action. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202104045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Annu, Sartaj A, Qamar Z, Md S, Alhakamy NA, Baboota S, Ali J. An Insight to Brain Targeting Utilizing Polymeric Nanoparticles: Effective Treatment Modalities for Neurological Disorders and Brain Tumor. Front Bioeng Biotechnol 2022;10:788128. [DOI: 10.3389/fbioe.2022.788128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Lakshmi BA, Kim YJ. Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications. Int J Mol Sci 2022;23:1641. [PMID: 35163563 DOI: 10.3390/ijms23031641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Fateh Basharzad S, Hamidi M, Maleki A, Karami Z, Mohamadpour H, Reza Saghatchi Zanjani M. Polysorbate-coated mesoporous silica nanoparticles as an efficient carrier for improved rivastigmine brain delivery. Brain Res 2022;:147786. [PMID: 35041841 DOI: 10.1016/j.brainres.2022.147786] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Şen Ö, Marino A, Pucci C, Ciofani G. Modulation of anti-angiogenic activity using ultrasound-activated nutlin-loaded piezoelectric nanovectors. Mater Today Bio 2022;13:100196. [PMID: 35005600 DOI: 10.1016/j.mtbio.2021.100196] [Reference Citation Analysis]
19 Mukherjee S, Madamsetty VS. Organic Nanoparticles in Anti-angiogenic Cancer Therapy. Nanoparticles in Angiogenesis and Cancer 2022. [DOI: 10.1007/978-3-031-11284-3_4] [Reference Citation Analysis]
20 Tao Q, Lin R, Chen Y, Wu Z. Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease. Aging and disease 2022;13:1391. [DOI: 10.14336/ad.2022.0130-1] [Reference Citation Analysis]
21 Raut A, Thorat ND. Niosomes based drug delivery in targeting brain tumors. Nanocarriers for Drug-Targeting Brain Tumors 2022. [DOI: 10.1016/b978-0-323-90773-6.00021-x] [Reference Citation Analysis]
22 Oak U, Khare T. Nanoparticle Functionalization: Approaches and Applications. Nanotechnology in the Life Sciences 2022. [DOI: 10.1007/978-3-031-10220-2_4] [Reference Citation Analysis]
23 Amiri M, Jafari S, Kurd M, Mohamadpour H, Khayati M, Ghobadinezhad F, Tavallaei O, Derakhshankhah H, Sadegh Malvajerd S, Izadi Z. Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood-Brain Barrier Transmitters. ACS Chem Neurosci 2021;12:4475-90. [PMID: 34841846 DOI: 10.1021/acschemneuro.1c00540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ribovski L, Hamelmann NM, Paulusse JMJ. Polymeric Nanoparticles Properties and Brain Delivery. Pharmaceutics 2021;13:2045. [PMID: 34959326 DOI: 10.3390/pharmaceutics13122045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
25 Xu L, Wang X, Liu Y, Yang G, Falconer RJ, Zhao C. Lipid Nanoparticles for Drug Delivery. Advanced NanoBiomed Research 2022;2:2100109. [DOI: 10.1002/anbr.202100109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
26 Ravichandran V, Lee M, Nguyen Cao TG, Shim MS. Polysorbate-Based Drug Formulations for Brain-Targeted Drug Delivery and Anticancer Therapy. Applied Sciences 2021;11:9336. [DOI: 10.3390/app11199336] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
27 Lynch MJ, Gobbo OL. Advances in Non-Animal Testing Approaches towards Accelerated Clinical Translation of Novel Nanotheranostic Therapeutics for Central Nervous System Disorders. Nanomaterials (Basel) 2021;11:2632. [PMID: 34685073 DOI: 10.3390/nano11102632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Sharma N, Zahoor I, Sachdeva M, Subramaniyan V, Fuloria S, Fuloria NK, Naved T, Bhatia S, Al-Harrasi A, Aleya L, Bungau S, Behl T, Singh S. Deciphering the role of nanoparticles for management of bacterial meningitis: an update on recent studies. Environ Sci Pollut Res Int 2021;28:60459-76. [PMID: 34545518 DOI: 10.1007/s11356-021-16570-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lin MH, Lai PS, Chang LC, Huang WC, Lee MH, Chen KT, Chung CY, Yang JT. Characterization and Optimization of Chitosan-Coated Polybutylcyanoacrylate Nanoparticles for the Transfection-Guided Neural Differentiation of Mouse Induced Pluripotent Stem Cells. Int J Mol Sci 2021;22:8741. [PMID: 34445447 DOI: 10.3390/ijms22168741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Ramírez García G, d'Orlyé F, Richard C, Mignet N, Varenne A. Electrokinetic elucidation of the interactions between persistent luminescent nanoprobes and the binary apolipoprotein-E/albumin protein system. Analyst 2021;146:5245-54. [PMID: 34296726 DOI: 10.1039/d1an00781e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Cortés H, Hernández-Parra H, Bernal-Chávez SA, Prado-Audelo MLD, Caballero-Florán IH, Borbolla-Jiménez FV, González-Torres M, Magaña JJ, Leyva-Gómez G. Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses. Materials (Basel) 2021;14:3197. [PMID: 34200640 DOI: 10.3390/ma14123197] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
32 Xue X, Wu Y, Xu X, Xu B, Chen Z, Li T. pH and Reduction Dual-Responsive Bi-Drugs Conjugated Dextran Assemblies for Combination Chemotherapy and In Vitro Evaluation. Polymers (Basel) 2021;13:1515. [PMID: 34066882 DOI: 10.3390/polym13091515] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
33 Azhari H, Younus M, Hook SM, Boyd BJ, Rizwan SB. Cubosomes enhance drug permeability across the blood-brain barrier in zebrafish. Int J Pharm 2021;600:120411. [PMID: 33675926 DOI: 10.1016/j.ijpharm.2021.120411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
34 Munjulury VSD, Calico R. Assessment of Modern Excipients in Controlled Delivery of Proteins and Peptides. J Drug Delivery Ther 2020;10:134-138. [DOI: 10.22270/jddt.v10i6-s.4631] [Reference Citation Analysis]
35 Khalin I, Severi C, Heimburger D, Wehn A, Hellal F, Reisch A, Klymchenko AS, Plesnila N. Dynamic tracing using ultra-bright labelling and multi-photon microscopy identifies endothelial uptake of poloxamer 188 coated poly(lactic-co-glycolic acid) nano-carriers in vivo.. [DOI: 10.1101/2020.11.19.385062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]